![Minori Rosales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Minori Rosales
Technik-/Wissenschafts-/F&E-Leiter bei
SYMBIO PHARMACEUTICALS LIMITED
Profil
Minori Rosales currently works at SymBio Pharmaceuticals Ltd., as Chief Medical Officer & Vice President from 2026.
Dr. Rosales also formerly worked at MedImmune LLC, as Vice President from 2017 to 2018, MacroGenics, Inc., as Vice President-Clinical Research from 2018 to 2022, Sesen Bio, Inc., as Chief Development Officer from 2022 to 2023, and Compass Therapeutics, Inc., as Senior Vice President & Head-Clinical Development from 2023 to 2025.
Dr. Rosales received her doctorate degree from Yamaguchi University and doctorate degree from Kansai Medical University.
Aktive Positionen von Minori Rosales
| Unternehmen | Position | Beginn |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2026 |
Ehemalige bekannte Positionen von Minori Rosales
| Unternehmen | Position | Ende |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2025 |
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2023 |
| MACROGENICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Minori Rosales
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Yamaguchi University
 Yamaguchi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Kansai Medical University
 Kansai Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
